SubHero Banner
Text

Emgality (galcanezumab-gnlm) – New drug approval

September 27, 2018 - Elli Lilly announced the FDA approval of Emgality (galcanezumab-gnlm) for the preventive treatment of migraine in adults.

Download PDF